Pezzoli G - Search Results

1

Major nutritional issues in the management of Parkinson's disease.

Barichella M, Cereda E, Pezzoli G. Barichella M, et al. Among authors: pezzoli g. Mov Disord. 2009 Oct 15;24(13):1881-92. doi: 10.1002/mds.22705. Mov Disord. 2009. PMID: 19691125 Free article. Review.

2

Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.

Pezzoli G, Martignoni E, Pacchetti C, Angeleri VA, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E, et al. Pezzoli G, et al. Mov Disord. 1994 Jul;9(4):431-6. doi: 10.1002/mds.870090409. Mov Disord. 1994. PMID: 7969210 Clinical Trial.

3

An overnight switch to ropinirole therapy in patients with Parkinson's disease. Short communication.

Canesi M, Antonini A, Mariani CB, Tesei S, Zecchinelli AL, Barichella M, Pezzoli G. Canesi M, et al. Among authors: pezzoli g. J Neural Transm (Vienna). 1999;106(9-10):925-9. doi: 10.1007/s007020050212. J Neural Transm (Vienna). 1999. PMID: 10599874

4

Hydrocarbon exposure and Parkinson's disease.

Pezzoli G, Canesi M, Antonini A, Righini A, Perbellini L, Barichella M, Mariani CB, Tenconi F, Tesei S, Zecchinelli A, Leenders KL. Pezzoli G, et al. Neurology. 2000 Sep 12;55(5):667-73. doi: 10.1212/wnl.55.5.667. Neurology. 2000. PMID: 10980731

5

Tolerability of paroxetine in Parkinson's disease: a prospective study.

Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani CB, Pezzoli G. Tesei S, et al. Among authors: pezzoli g. Mov Disord. 2000 Sep;15(5):986-9. doi: 10.1002/1531-8257(200009)15:5<986::aid-mds1034>3.0.co;2-i. Mov Disord. 2000. PMID: 11009210 Clinical Trial.

6

Is underweightness still a major problem in Parkinson's disease patients?

Barichella M, Marczewska A, Vairo A, Canesi M, Pezzoli G. Barichella M, et al. Among authors: pezzoli g. Eur J Clin Nutr. 2003 Apr;57(4):543-7. doi: 10.1038/sj.ejcn.1601581. Eur J Clin Nutr. 2003. PMID: 12700615

7

Body weight gain rate in patients with Parkinson's disease and deep brain stimulation.

Barichella M, Marczewska AM, Mariani C, Landi A, Vairo A, Pezzoli G. Barichella M, et al. Among authors: pezzoli g. Mov Disord. 2003 Nov;18(11):1337-40. doi: 10.1002/mds.10543. Mov Disord. 2003. PMID: 14639677

8

Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration.

Antonini A, Goldwurm S, Benti R, Prokisch H, Ebhardt M, Cilia R, Zini M, Righini A, Cossu G, Pezzoli G. Antonini A, et al. Among authors: pezzoli g. Mov Disord. 2006 Mar;21(3):417-8. doi: 10.1002/mds.20774. Mov Disord. 2006. PMID: 16267847

9

Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.

De Gaspari D, Siri C, Landi A, Cilia R, Bonetti A, Natuzzi F, Morgante L, Mariani CB, Sganzerla E, Pezzoli G, Antonini A. De Gaspari D, et al. Among authors: pezzoli g. J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):450-3. doi: 10.1136/jnnp.2005.078659. J Neurol Neurosurg Psychiatry. 2006. PMID: 16543520 Free PMC article.

10

Clinical correlates and cognitive underpinnings of verbal fluency impairment after chronic subthalamic stimulation in Parkinson's disease.

De Gaspari D, Siri C, Di Gioia M, Antonini A, Isella V, Pizzolato A, Landi A, Vergani F, Gaini SM, Appollonio IM, Pezzoli G. De Gaspari D, et al. Among authors: pezzoli g. Parkinsonism Relat Disord. 2006 Jun;12(5):289-95. doi: 10.1016/j.parkreldis.2006.01.001. Epub 2006 Mar 22. Parkinsonism Relat Disord. 2006. PMID: 16554183 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters